Conmed Corp.
CNMD
Market Cap$2.16B
Close$
$18.71
73.6% downside
Current Fair Value
73.6% downsideOvervalued by 73.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.16 Billion |
|---|---|
| Enterprise Value | $3.12 Billion |
| Dividend Yield | $0.7975 (1.14%) |
| Earnings per Share | $2.61 |
| Beta | 0.89 |
| Outstanding Shares | 30,800,747 |
| Avg 30 Day Volume | 672,842 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 26.23 |
|---|---|
| PEG | 2.67 |
| Price to Sales | 1.77 |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 2.47 |
| Enterprise Value to EBIT | 21.81 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 1.16 |
Revenue Sources
No data
ESG Score
No data
About Conmed Corp.
CEO: Curt Hartman